#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-small cell lung cancer Pemphigus Essential thrombocythaemia Non-renal cell carcinoma of kidney Synovial sarcoma Chronic granulomatous disease Osteochondrodysplasia Pituitary-dependent Cushing's syndrome Tuberous sclerosis complex Philadelphia chromosome positive Primary amyloidosis Univentricular heart Extra-osseous Ewing's sarcoma metastatic Arrhythmia Immune-mediated myositis More trials…

    Learn about Rare Diseases

    Angiosarcoma – Life with Disease Proteus syndrome – Treatment Congenital generalised lipodystrophy Leiomyosarcoma recurrent – Diagnostics Immunodeficiency congenital – Life with Disease VEXAS syndrome – Trials in Disease Undifferentiated sarcoma – Basic Information Hereditary ataxia – Basic Information Antithrombin III deficiency – Trials in Disease Bronchopulmonary dysplasia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Heparin Calcium Heterodimeric Interleukin-15 Efanesoctocog Alfa AZD0516 Fluocinolone Acetonide Vx-670 Autologous Microfat Valsartan ASP2957 Agrostis Stolonifera Pollen Palmidrol Pilocarpine Hydrochloride GSKVX000000034795 Lomustine Voxelotor Ripretinib Bexmarilimab Relugolix Viltolarsen Propranolol Hydrochloride More therapies…

    Learn about Your Condition

    Acute myocardial infarction Myotonia Endocarditis Cardiac disorder Lipid metabolism disorder Tricuspid valve disease Bartonellosis Colorectal adenoma Pemphigoid Immunodeficiency Corneal graft failure Ureteric cancer Breast cancer female Congenital myopathy Small intestine adenocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Faricimab for Caucasian Patients with Polypoidal Choroidal Vasculopathy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polypoidal choroidal vasculopathy
    Investigated Drugs:
    • Faricimab
    Italy Portugal Spain

  • Study on JX10 for Improving Outcomes in Patients with Acute Ischemic Stroke

    Recruiting

    4 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • JX10
    Belgium Bulgaria Finland France Germany Greece +7

  • Study on Darolutamide for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Darolutamide
    Sweden

  • Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Iron deficiency
    Investigated Drugs:
    • Ferric Derisomaltose
    Bulgaria Croatia Czechia Denmark Hungary Latvia +6

  • Study on the Effects and Safety of Finerenone for Patients with Heart Failure Who Cannot Use Steroidal Mineralocorticoid Receptor Antagonists

    Recruiting

    3 1
    Investigated Drugs:
    • Finerenone
    Croatia Czechia Greece Hungary Italy Poland +1

  • Study on the Effectiveness of Gaxilose for Diagnosing Lactose Intolerance in Children Aged 5 to 11 Years

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • GAXILOSE
    Spain
Previous Page
1 … 179 180 181 182 183 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!